当前位置:首页 - 行情中心 - 沃森生物(300142) - 财务分析

沃森生物

(300142)

  

流通市值:170.44亿  总市值:174.81亿
流通股本:15.59亿   总股本:15.99亿

沃森生物(300142)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.20亿元,每股收益0.00元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益1148818.18万元,未分配利润303164.97万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产1436408.41万元,负债287590.23万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入462,257,650.832,821,441,302.712,141,346,183.011,433,348,556.33
营业总成本426,650,521.542,531,774,103.411,756,031,473.681,178,655,595.05
营业利润-13,576,069.5296,674,057.99286,082,966.34188,416,703.18
利润总额-14,770,200.32184,502,101.62373,789,190.09277,693,243.15
净利润-19,682,659.04174,397,875.24350,640,884.9257,516,127.05
其他综合收益--45,900,000--
综合收益总额-19,682,659.04128,497,875.24350,640,884.9257,516,127.05
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计6,748,867,229.37,066,828,580.517,397,846,398.357,492,655,026.81
非流动资产合计7,615,216,822.157,657,483,328.747,605,862,604.547,593,597,678.92
资产总计14,364,084,051.4514,724,311,909.2515,003,709,002.8915,086,252,705.73
流动负债合计2,061,239,206.082,370,002,301.992,389,955,735.472,549,273,542.29
非流动负债合计814,663,092.61846,445,195.46883,745,845.96900,096,499.83
负债合计2,875,902,298.693,216,447,497.453,273,701,581.433,449,370,042.12
归属于母公司股东权益合计9,432,189,382.259,429,543,133.679,589,641,343.389,503,843,180.38
股东权益合计11,488,181,752.7611,507,864,411.811,730,007,421.4611,636,882,663.61
负债和股东权益合计14,364,084,051.4514,724,311,909.2515,003,709,002.8915,086,252,705.73
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计461,359,189.823,597,730,735.82,578,934,372.581,565,090,966.31
经营活动现金流出小计623,034,112.662,561,206,208.32,019,529,731.211,474,494,573.76
经营活动产生的现金流量净额-161,674,922.841,036,524,527.5559,404,641.3790,596,392.55
投资活动现金流入小计827,6245,362,807.514,874,532.2247,130
投资活动现金流出小计70,445,611.451,272,029,878.51,177,299,885.811,036,983,127.86
投资活动产生的现金流量净额-69,617,987.45-1,266,667,070.99-1,172,425,353.59-1,036,935,997.86
筹资活动现金流入小计-38,399,016.1538,399,016.1538,399,016.15
筹资活动现金流出小计27,352,521.09409,429,658.57156,366,612.13122,451,646.17
筹资活动产生的现金流量净额-27,352,521.09-371,030,642.42-117,967,595.98-84,052,630.02
汇率变动对现金及现金等价物的影响19,876.895,413,290.34-5,461,839.45836,946.9
现金及现金等价物净增加额-258,625,554.49-595,759,895.57-736,450,147.65-1,029,555,288.43
期末现金及现金等价物余额3,500,477,261.523,759,102,816.013,618,412,563.933,325,307,423.15
最新报告期:2025-06-12
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信建投刘若飞,贺菊颖0.130.160.192025-06-12
中信证券陈竹0.220.270.322025-05-19
TOP↑